Navigation Links
AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
Date:1/27/2011

ALISO VIEJO, Calif., Jan. 27, 2011 /PRNewswire/ -- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that it will release unaudited financial results for the quarter ended December 31, 2010 before market open on Thursday, February 3, 2011.  Keith Katkin, President and Chief Executive Officer, Randall Kaye, M.D., Senior Vice President and Chief Medical Officer, and Christine Ocampo, Vice President, Finance, will host an investment community conference call that same day at 6:00 a.m. Pacific time / 9:00 a.m. Eastern time to discuss those results and answer questions.

Investors are invited to listen to the live webcast by visiting AVANIR's corporate website at www.avanir.com.  To listen to the live call, please go to AVANIR's website prior to the start of the call to register, download and install the necessary audio software.

An archived copy of the webcast will be available on AVANIR's website for 30 days, and a telephone replay will be available through February 8, 2011, by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering the conference ID number 40636357.

About AVANIR

AVANIR Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need.  As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones.  For more information about AVANIR, please visit www.avanir.com.  


'/>"/>
SOURCE AVANIR Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
2. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
3. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
4. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
5. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
6. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
7. Amylin Pharmaceuticals Reports 2010 Financial Results
8. Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team
9. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
10. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
11. Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... 2016 The global dental bone ... a CAGR of 10.6% within a forecast period from ... bn in 2013. Owing to favorable factors at play ... bn by the end of this forecast period, i.e. ... holistic representation in a research report published by Transparency ...
(Date:5/31/2016)... NESS ZIONA, Israel , ... a regenerative medicine company utilizing its proprietary plant-based rhCollagen ... has received authorization from the Chief Scientist of ... approximately 50% of its NIS 12 million development project ... million, measurably higher than last year,s authorized grant, which ...
(Date:5/30/2016)... , May 30, 2016 ... research report "Healthcare Biometrics Market by Technology ... Voice)), Multifactor, Multimodal), Application (Workforce Management), End ... to 2021", published by MarketsandMarkets, the market ... by 2021 from USD 1,182.6 Million by ...
Breaking Medicine Technology:
(Date:5/31/2016)... , ... May 31, 2016 , ... Throughout the day, adults often find themselves reaching ... and awareness, but what they could be reaching for instead is a cup of Matcha ... are grown in Japan. This sacred tea is harvested from early June to mid-July, when ...
(Date:5/31/2016)... ... May 31, 2016 , ... Presence ... it has been included by Gartner, Inc. in the Contact Center Infrastructure Magic ... Contact Center Infrastructure technologies, some of which include: Computer-telephony integration (CTI)/Web services ...
(Date:5/31/2016)... TEXAS (PRWEB) , ... May 31, 2016 , ... ... live in Greater Houston Healthconnect’s (Healthconnect) regional health information exchange, which enables physicians ... medical records for their patients from other participating organizations in the exchange. SJMC’s ...
(Date:5/31/2016)... GA (PRWEB) , ... May 31, 2016 , ... ... readmissions using a mix of advanced Artificial Intelligence (AI) and the latest in ... solution. The medical center is integrating predictive analytic outputs directly into the clinical ...
(Date:5/31/2016)... ... 31, 2016 , ... DDL, Inc. announced today it has expanded the scope ... include ISO 594-1 and ISO 594-2 testing for conical (Luer) fittings. , A ... two medical devices (e.g. a syringe and hypodermic needle) that carry small volumes of ...
Breaking Medicine News(10 mins):